It was previously reported that antibodies to MOG were detected in some AQP4‐Ab negative patients manifesting clinical and neuroimaging signs of NMO or NMOSD (Zamvil & Slavin, 2015). The gene discussed is AQP4; the disease is neuromyelitis optica.